---
title: "Oruka Therapeutics (ORKA) Receives a Rating Update from a Top Analyst"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282540371.md"
description: "BTIG analyst Julian Harrison has maintained a Buy rating on Oruka Therapeutics (ORKA) with a price target of $78.00. Harrison, a top 100 analyst with a 37.6% average return, suggests a Strong Buy consensus for ORKA, with an average price target of $74.55. He also covers other healthcare stocks like Apogee Therapeutics and MoonLake Immunotherapeutics."
datetime: "2026-04-13T11:43:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282540371.md)
  - [en](https://longbridge.com/en/news/282540371.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282540371.md)
---

# Oruka Therapeutics (ORKA) Receives a Rating Update from a Top Analyst

BTIG analyst Julian Harrison maintained a Buy rating on Oruka Therapeutics today and set a price target of $78.00.

### Easter Sale - 70% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Harrison is a top 100 analyst with an average return of 37.6% and a 54.69% success rate. Harrison covers the Healthcare sector, focusing on stocks such as Apogee Therapeutics, MoonLake Immunotherapeutics, and Spyre Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Oruka Therapeutics with a $74.55 average price target.

### Related Stocks

- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [BUZZ-Oruka Therapeutics rises after upsized $700 mln stock offering](https://longbridge.com/en/news/284555655.md)
- [Oruka Therapeutics Commences Public Offering Of $500 Mln Of Shares And Warrants](https://longbridge.com/en/news/284342940.md)
- [Aligos Therapeutics (ALGS) Gets a Buy from H.C. Wainwright](https://longbridge.com/en/news/283864894.md)
- [Oruka Therapeutics Prices Upsized $700 Mln Offering To Advance Psoriasis Pipeline](https://longbridge.com/en/news/284478592.md)
- [Aclaris Therapeutics Says Positive Full Top Line Results From Phase 1A Clinical Trial Of ATI-055](https://longbridge.com/en/news/284363314.md)